Compare AXT Inc (AXTI) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AXT Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? AXT Inc trades at $79.32 (market cap $4.83B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: AXT Inc is far larger — about 9.6× Ginkgo Bioworks Holdings Inc's market cap, and AXT Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| AXTI | DNA | |
|---|---|---|
Market Cap | $4.83B | $505.73M |
Sector | Technology | Health |
52-Week High | $140.83 | $16.14 |
52-Week Low | $2.05 | $5.48 |
Enterprise Value | $4.50B | $607.68M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AXT Inc
AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.
Read more on AXTI →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
